SCHEMBL1275985

SCHEMBL1275985

CCOC(=O)Nc1ccc(F)c(F)c1C#C[Si](C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
KCNQ2 O43526 7/20 0.42
KCNQ3 O43525 6/20 0.42
KCNQ4 P56696 4/20 0.41
KCNQ5 Q9NR82 3/20 0.41
ABCB11 O95342 1/20 0.41
ESR1 P03372 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CYP2D6 P10635 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
TBXA2R P21731 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1984373 0.80 NLRP3 (0.46) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL9376422 0.78 CYP1A2 (0.58) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL2536549 0.77 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL404925 0.75 CYP1A2 (0.60) CYP1A2CYP2C9CYP2C19SMN1; SMN2CYP3A4
SCHEMBL1274750 0.75 NLRP3 (0.39) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL2036580 0.75 NLRP3 (0.41) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL1275026 0.74 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2
SCHEMBL6087268 0.74 NLRP3 (0.47) CYP1A2CYP2C9CYP2C19SMN1; SMN2HSD17B10
SCHEMBL6107295 0.74 ALDH1A1 (0.44) CYP1A2CYP2C9CYP2C19SMN1; SMN2ALOX15
SCHEMBL7008609 0.73 KCNQ2 (0.62) CYP1A2CYP2C9CYP2C19SMN1; SMN2KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480232-B1 DISUBSTITUTED ]4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES SANOFI SA (FR) 2013-10-02 EP disclosed
EP-2480232-B1 DISUBSTITUTED ]4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES SANOFI SA (FR) 2013-10-02 EP disclosed
EP-2480232-A1 DISUBSTITUTED ]4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES SANOFI (FR) 2012-08-01 EP disclosed
US-20120142735-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES SANOFI (FR) 2012-06-07 US disclosed
US-20120142735-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES SANOFI (FR) 2012-06-07 US disclosed
WO-2011022449-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES SANOFI-AVENTIS (FR) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142735-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES CMA1, TPSB2, TPSAB1 CYP1A2 203/4885CYP2C9 257/4885CYP2C19 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.